Today's Change
+0.85%
AI Sentiment
64%
Sector AnalysisLive data
Materials Sector Outlook
The Materials sector is up 0.85% today with bullish sentiment across 9 recent news articles. Top movers include $CDTTW (+65.33%), $ERNAW (+63.87%), $TMCWW (+60.68%).
Bullish Factors
- No strong bullish signals detected
Risk Factors
- No strong bearish signals detected
Stocks in Materials
198 stocks| Symbol | Company | Change |
|---|---|---|
| $NBY | NovaBay Pharmaceuticals, Inc. | +0.00% |
| $TMCWW | TMC the metals company Inc - Warrants (09/09/2026) | +60.68% |
| $SCLXW | Scilex Holding Company - Warrants (10/11/2027) | -6.43% |
| $RVMDW | Revolution Medicines Inc - Warrants (17/12/2026) | +4.86% |
| $ENGNW | enGene Holdings Inc - Warrants (31/10/2028) | +11.50% |
| $SDSTW | Stardust Power Inc - Warrants (21/06/2029) | -2.69% |
| $SBFMW | Sunshine Biopharma Inc - Warrants (15/02/2027) | +0.00% |
| $JSPRW | Jasper Therapeutics Inc - Warrants (24/09/2026) | -15.64% |
| $BIVIW | BioVie Inc Warrant | +9.38% |
| $BCTXL | BriaCell Therapeutics Corp Warrants | +7.53% |
| $ERNAW | Ernexa Therapeutics Inc Warrants | +63.87% |
| $SRZNW | Surrozen Inc - Warrants (01/08/2026) | +5.00% |
| $CDIOW | Cardio Diagnostics Holdings Inc - Warrants (01/12/2026) | -11.72% |
| $BCTXZ | BriaCell Therapeutics Corp Warrant | -13.56% |
| $ASBPW | Aspire Biopharma Holdings Inc - Warrants (18/02/2030) | +7.88% |
Materials News
807 articles
Benzinga19d ago
U.S. GoldMining Mobilizes 2026 Exploration Program Targeting District-Scale Potential at the Whistler Project, Alaska
GlobeNewswire Inc.19d ago
Prelude Therapeutics Presents Preclinical Data from Development Candidate, PRT13722, a First-in-Class, Orally Bioavailable, Potent and Highly Selective KAT6A Degrader at American Association for Cancer Research (AACR) Annual Meeting 2026
GlobeNewswire Inc.19d ago
Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026
GlobeNewswire Inc.19d ago
Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-α-NET in Its Ongoing Phase 1/2a Clinical Trial at the 2026 AACR Annual Meeting
GlobeNewswire Inc.19d ago
USA Rare Earth Announces Definitive Agreement to Acquire Serra Verde Group for ~$2.8 Billion, Creating the Global Rare Earth Leader
GlobeNewswire Inc.19d ago
Bombardier and Vista Sign Service Agreement Focused on Smart Parts Programs
GlobeNewswire Inc.19d ago
Bombardier et Vista signent une entente de services axée sur les programmes Smart Parts
GlobeNewswire Inc.20d ago
Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026
GlobeNewswire Inc.20d ago
Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting
GlobeNewswire Inc.20d ago
KIMMTRAK doubles the likelihood of being alive at five years for first line HLA-A*02:01+ patients with metastatic uveal melanoma
GlobeNewswire Inc.20d ago
Revolution Medicines to Present Updated Phase 1 Clinical Data for Zoldonrasib in Patients with Previously Treated KRAS G12D Non-Small Cell Lung Cancer at the 2026 AACR Annual Meeting
GlobeNewswire Inc.20d ago
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AQST
Market Sentiment
Bullish
64% Sentiment Score
Sector Stats
Total Stocks198
News Today9
Avg Volume1.3M
AI SentimentBullish